Corteva, Inc. (NYSE:CTVA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-three research firms that are presently covering the firm, MarketBeat Ratings reports. Nine analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $91.50.
A number of research analysts recently issued reports on CTVA shares. Barclays lifted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. BNP Paribas Exane lifted their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Oppenheimer boosted their price target on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. Bank of America raised their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research report on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 price objective on shares of Corteva in a research note on Monday, August 3rd.
View Our Latest Stock Report on CTVA
Institutional Inflows and Outflows
Corteva Price Performance
CTVA opened at $84.00 on Tuesday. The stock has a fifty day simple moving average of $82.69 and a two-hundred day simple moving average of $80.54. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a market cap of $56.04 billion, a price-to-earnings ratio of 55.63, a price-to-earnings-growth ratio of 2.58 and a beta of 0.57. Corteva has a 12-month low of $60.53 and a 12-month high of $90.97.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same quarter last year, the firm posted $2.20 earnings per share. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts predict that Corteva will post 3.72 earnings per share for the current fiscal year.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 47.68%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
